|
Exhibition Floor Plan
 General overview of the Exhibition Hall
Exhibitors’ product descriptions and stand numbers
A.Menarini Pharmaceuticals Ireland Ltd. S10
Castlecourt
Monkstown Farm
Monkstown
CCo. Dublin
Ireland
Fax : +353 1 284 6769
Email: ireland@menarini.ie
A.Menarini Pharmaceuticals, Ireland Ltd., is a subsidiary of A.Menarini Farmaceutiche Rinuite, an Italian Research and Development pharmaceutical company established in 1886 and trading in over 100 countries. The Irish operation, employing 37 staff, began trading in October 1999. A.Menarini Ireland has been a significant contributor to continuing medical education since it was founded. Therapeutic areas include cardiology, analgesia, osteoporosis and immunology. In 1999 Nebilet (Nebivolol), a third generation vasodilating beta-blocker, was launched, indicated for essential hypertension, and more recently for stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients > 70 years. In January 2004 Omesar (Olmesartan Medoxomil) an ARB, indicated for essential hypertension was launched, This was followed in May 2006 with Omesar Plus (Olmesartan medoxomil and hydrochlorothiazide), a fixed dose combination for the treatment of essential hypertension. The company looks forward to introducing other novel therapies in cardiovascular medicine.
AstraZeneca S5
College Park House
20 Nassau Street
Dublin 2
Ireland
Tel: +353 1 609 7100
Fax: +353 1 679 6650
Email: kathy.wray@astrazeneca.com
Web Site: http://www.astrazeneca.com/
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services.
As one of the world's leading pharmaceutical companies AstraZeneca provides a wide range of innovative, effective medicines in important areas of medical need such as; cancer, cardiovascular, gastrointestinal, infection, neuroscience, pain control and respiratory.
Boehringer Ingelheim S4
Corrig Court, Corrig Road
Sandyford Business Park
Dublin 18
Ireland
Fax Number: +353 1 2969624
Email: barry.walsh@boehringer-ingelheim.com
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies.
Micardis (telmisartan) is an angiotensin receptor blocker, approved for the treatment of hypertension.
Bristol-Myers Squibb S1
South County Business Park
Leopardstown
D18 Dublin
Ireland
Fax: +353 12913899
Email: fiona.concannon@bms.com
Web Site: http://www.bms.com/
Bristol-Myers Squibb is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.
Sanofi-Aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.
Plavix® is indicated for the reduction of atherothrombotic events in patients with a history of recent MI, recent stroke or established peripheral arterial disease (P.A.D.) Plavix® is also indicated for patients with NSTEMI ACS, including those who are to be managed medically and those managed with PCI (with or without a stent) or CABG. Additionally Plavix® is indicated in STEMI patients.
British Journal of Cardiac Nursing S19
St Jude's Church
Dulwich Road
Herne Hill
SE24 0PB London
United Kingdom
Tel: +44 (0)207 738 5454
Fax: +44 (0)27 733 2325
Email: stacy.s@markallengroup.com
Web Site: http://www.cardiac-nursing.co.uk/
British Journal of Cardiac Nursing is a clinical and professional review journal for nurses who wish to be fully informed of developments in the specialty of cardiac nursing.
It aims to provide the highest standards of clinical reviews and reflects the different contexts in which nurses operate, whether working in a hospital-based unit or ward or within primary care.
Cordis, a Johnson and Johnson Company S23
Airton Rd.
Tallaght
Dublin 24
Ireland
Tel: +353 879 397 843
Fax: + 353 1 4665314
Email: efitzgerald@its.jnj.com
Web Site: http://www.jnj.com/
Cordis is driven to transform the future of vascular care. Cordis has a history of scientific breakthroughs-from catheters, to stents, to the powerful marriage of drugs and medical devices. We are continually searching out new treatments to help conquer circulatory disease such as heart disease, thrombosis and stroke, changing forever the lives of patients, doctors and healthcare professionals.
And, as a Johnson & Johnson company, Cordis can draw on the kinds of resources that make breakthrough treatments possible. Cordis do things right- working tirelessly around the globe to pursue new, more powerful therapies, making significant investments in R&D, pursuing the most rigorous clinical trials and working collaboratively with the healthcare community to define where the next advance is needed. All with the goal that no one lives a life diminished by vascular disease
DAIICHI SANKYO S3
3013 Lake Drive
City West Business Campus
Naas Road
Dublin 24
Ireland
Fax: +353 1 489 3033
Email: info@daiichi-sankyo.ie
Web Site: http://www.daiichi-sankyo.ie/
DAIICHI SANKYO IRELAND LTD, an affiliate of DAIICHI SANKYO COMPANY LIMITED began trading in Ireland in November 2008. DAIICHI SANKYO is one of the top 3 pharmaceutical companies in Japan and one of the top 20 global research-focused pharmaceutical companies. DAIICHI SANKYO has its own marketing and sales offices in 12 European Markets. The Irish Operation currently employs 16 people.
European Headquarters are based in Munich, Germany.
Products Portfolio
Cardicor, Emcor, Glucophage (co-promotion), Benetor, Benetor Plus, Evista
EUROPEAN SOCIETY OF CARDIOLOGY S18
2035 Routes des Colles
Les Templiers, BP 179
06903 SOPHIA ANTIPOLIS
France
Tel: +33 4 92 94 76 00
Fax: +33 4 92 94 86 69
Email: communications@escardio.org
Web Site: http://authors.escardio.org/
The European Society of Cardiology (ESC) represents over 59,000 cardiology professionals from across Europe and the Mediterranean. The ESC comprises 51 National Cardiac Societies, 19 Working Groups, 5 Associations and 5 Councils. It also includes the distinguished community of ESC Fellows and Nurse Fellows. Its mission is "To reduce the burden of cardiovascular disease in Europe". The ESC achieves this through a series of scientific and educational activities and its Annual Congress, the largest medical meeting in Europe, this year from 29 August -2 September 2009 in Barcelona, Spain.
ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP) S18
2035 Route des Colles
Les Templiers – BP 179
06903 Sophia Antipolis
France
Tel: +33 4 92 94 76 00
Fax: +33 4 92 94 86 69
Email: councils@escardio.org
Web Site: http://authors.escardio.org/Nursing
The ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP) provides an umbrella to coordinate the activities of cardiovascular nurses and allied professionals within the various groups of the European Society of Cardiology. It is devoted to promoting excellence in Cardiovascular Nursing and Allied Professions through practice, education and research.
Learn more on the Council and its activities at the ESC – CCNAP stand. Find out how to apply for Travel Grants for the Annual Spring Meeting and the ESC Congress. Check on how to become a member - membership is free and entitles you to apply for awards.
The Annual Spring Meeting is the opportunity to network with professionals in cardiovascular nursing and to present your work by submitting abstracts. Our staff will be delighted to provide information on the Annual Spring Meeting 2010.
HOSPITAL SERVICES LTD S16
BALLYMOSS ROAD
SANDYFORD INDUSTRIAL ESTATE
DUBLIN 18
Ireland
Tel: +353 1 1950500
Fax: +353 1 2950555
Email: sales@hsl.ie
Web Site: http://www.hsl.ie/
Spacelabs 24 Hour Blood Pressure monitors
Irish Nurses Cardiovascular Association S20
c/o Irish Heart Foundation
4 Clyde Road
Ballsbridge
Dublin 4
Ireland
Email: oconnormar@gmail.com
Web Site: http://www.incanursing.ie/
Irish Nurses Cardiovascular Association was formed to encourage nurses working within this area to meet on a regular basis and to exchange views and research on their work.
The aim of the Association is to provide a forum for education, communication and research development among members working in the field of cardiovascular nursing.
The objective of the Association is to keep members informed of new developments relating to cardiovascular disease and to promote and provide ongoing research and education for nurses. The objective is also to enhance the standards of nursing care and nursing research.
Over the years membership numbers and activities have grown steadily and the focus of the Association has evolved to encompass the broad range of cardiovascular nursing specialities. The INCA is now the major scientific group for nurses working in the field of cardiovascular disease.
Irish Heart Foundation S9
4 Clyde Road
Ballsbridge
Dublin 4
Ireland
Tel: +353 1 6685001
Fax: +353 1 6685896
Email: moshea@irishheart.ie
Web Site: http://www.irishheart.ie/
National Charity for Heart Health whose mission is to reduce premature death and disability from Heart Disease and Stroke.
Merck Sharp & Dohme Ireland (Human Health) Ltd. S2
South County Business Park
Leopardstown
Dublin 18
Ireland
Tel: +353 1 299 8700
Fax: +353 1 299 8701
Email: susie_pittock@merck.com
Web Site: http://www.msd.ie/
Merck Sharp & Dohme Ireland (Human Health) Ltd. will launch TREDAPTIVE in Ireland in 2009.
TREDAPTIVE is indicated for the treatment of dyslipidaemia, particularly in patients with combined mixed dyslipidaemia (characterised by elevated levels of LDL cholesterol and triglycerides and low HDL cholesterol) and in patients with primary hypercholesterolaemia (heterozygous familial and non familial).
TREDAPTIVE should be used in patients in combination with HMG CoA reductase inhibitors (statins), when the cholesterol lowering effect of HMG CoA reductase inhibitor monotherapy is inadequate. It can be used as monotherapy only in patients in whom HMG CoA reductase inhibitors are considered inappropriate or not tolerated. Diet and other non pharmacological treatments (e.g. exercise, weight reduction) should be continued during therapy with TREDAPTIVE.
National Council for the Professional development of Nursing and Midwifery S22
6/7 Manor Business Park
Manor Street
Dublin 7
Ireland
Email: mfarrelly@ncnm.ie
Web Site: http://www.ncnm.ie/
The purpose of the Council is to promote and develop the professional roles of nurses and midwives in partnership with stakeholders in order to support the delivery of quality nursing and midwifery care to patients/clients in a changing healthcare environment.
Novartis S6
Beech House
Clonskeagh
Dublin 4
Ireland
Fax: +353 12601263
Email: jason.davies@novartis.com
Hypertension
Pfizer Healthcare S13
9, Riverwalk, National Digital Park,
Citywest Business Campus,
Dublin 24
Ireland
Fax: +353 14676680
Email: jennifer.slattery@pfizer.com
Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, more than 80,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide
PHYSIO-CONTROL S8
C/o Medtronic Ireland, Unit GA
Swords Business Campus,
Balheary Road
Swords
Dublin
Ireland
Tel: +35315111499
Fax: +35318077220
Email: csd.ireland@medtronic.com
Web Site: http://www.physio-control.com/ & http://www.lucas-cpr.com/
Physio-Control, a division of Medtronic since 1997– designs, manufactures, sells, services and supports the LIFEPAK® range of defibrillator/monitors, used in pre-hospital and in-hospital markets. Additionally they make Automated External Defibrillators (AEDs) - which are increasingly being installed in public places, such as businesses, airports, shopping centre’s and homes.Physio-Control also globally distributes the LUCAS® Chest Compression system which will be on display at the CCNAP meeting.
Preventive Cardiovascular Nurses Association S17
613 Williamson St., Ste 200
53703 Madison, WI
United States
Fax: +1 6082502410
Email: info@pcna.net
Web Site: http://www.pcna.net/
PCNA is the leading nursing organization dedicated to preventing cardiovascular disease (CVD) through assessing risk, facilitating lifestyle changes, and guiding individuals to achieve treatment goals.
Recordati Ireland S14
Raheens East,
Ringaskiddy,
Cork
Ireland
Tel: +353 21 4379400
Fax: +353 21 4379280
Email: burns.e@recordati.ie
Web Site: http://www.recordati.com/
We are a European specialty pharmaceutical group dedicated to partnering, discovering and developing innovative, value-added products that improve quality of life and help people to enjoy longer, healthier and more productive lives. Recordati Ireland has a production facility in Cork, which manufactures our Calcium Channel Blocker Lercanidipine (Zanidip). Our Sales & Marketing division concentrate on two theraputic areas, Cardiovascular (Zanidip & Lercaril) and Urology (Kentera for Overactive Bladder). We have recently launched our new combination product Lercaril (enalapril/lercanidipine) for hypertension.
Roche Diagnostics Ltd S7
Charles Avenue
Burgesshill
RH15 9RY West Sussex
United Kingdom
Fax: +44 1444256205
Email: burgesshill.cardiacpoc@roche.com
Web Site: http://www.cardiovascularcare.com/
Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. In April 2007 we launched our first portable cardiac reader, the Cobas h232, designed for use in hospital and by GPs. It has a broad menu including tests for deep vein thrombosis and pulmonary embolism as well as myocardial infarction and heart failure. Results are given on the spot, delivering accuracy comparable to a laboratory and enabling swift diagnosis and treatment.
Schering-Plough Pharmaceuticals (Ireland) Limited S15
6th Floor, Block 14 (North Block)
Rockfield Central, Dundrum
Dublin 16
Ireland
Website: http://www.schering-plough.com/
Servier Laboratories (Ireland) Ltd S12
Block 2, West Pier Business Campus
Old Dunleary Road
Dun Laoghaire
Dublin
Ireland
Fax: +353 1 6638120
Email: information@ie.netgrs.com
Web Site: http://www.servier.ie/
Servier Laboratories have innovative drugs in areas such as:
Neurosciences
Oncology
Cardiovascular disease
Metabolic disease
Rheumatology
All Servier drugs currently produced were developed by Servier's own Research and Development team.
St Jude Medical S11
St Jude Medical Coordination Center
Davincilaan 11 box F1
1935 Zaventem
Belgium
Tel: +3227746780
Fax: +3227746843
Web Site: http://www.sjm.com/
Company & Product Description St. Jude Medical develops medical technology designed to put more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful patient outcomes. Learn more at sjm.com
|